摘要目的:分析和对比植入式静脉输液港与PICC在卵巢癌化疗患者中的应用效果。方法:选择该院自2018年1月至2019年12月收治的80例卵巢癌患者作为研究对象，采用随机数字表法将其分成对照组和研究组，每组40例，两组患者均行化疗治疗，化疗过程中，对照组采用PICC行静脉化疗，研究组采用植入式静脉输液港行静脉化疗，对比两组患者一次置管成功率、置管花费时间、导管留置时间、导管留置期间并发症发生率。结果:对照组患者一次置管成功率(95.00%)显著高于研究组(80.00%)，差异有统计学意义( P<0.05)。研究组患者置管花费时间(37.16±3.07)min、导管留置时间(13.55±1.08)d均显著长于对照组(20.18±2.32)min、(7.14±0.86)d，差异有统计学意义( P<0.05)。研究组患者导管留置期间并发症发生率(7.50%)显著低于对照组(30.00%)，差异有统计学意义( P<0.05)。 结论:在卵巢癌化疗患者中应用植入式静脉输液港与PICC均具有其各自的优势，其中PICC具有操作简便、置管成功率高等优势，而植入式静脉输液港则具有留置时间长、并发症少等优势，临床可根据患者实际情况为其选择合适的静脉化疗途径。

abstractsObjective:To analyze and compare the effect of implantable intravenous infusion port and Peripherally Inserted Central Catheter(PICC)in patients with ovarian cancer undergoing chemotherapy.Methods:A total of 80 patients with ovarian cancer treated in this hospital from January 2018 to December 2019 were randomly divided into control group ( n=40) and study group ( n=40). Both groups were treated with chemotherapy.During chemotherapy, the control group was treated with intravenous chemotherapy with PICC, and the study group was treated with intravenous chemotherapy with implantable intravenous infusion port.The success rate of one-time catheterization, the time spent in catheterization, the time of catheter indwelling and the incidence of complications during catheter indwelling were compared between the two groups. Results:The success rate of primary catheterization in the control group (95.00%) was significantly higher than that in the study group (80.00%), and the difference was statistically significant( P<0.05). The time of catheterization (37.16 ±3.07) minutes and catheter indwelling(13.55±1.08)days were significantly longer than those in the control group (20.18±2.32) minutes, (7.14 ±0.86)days, and the differences were statistically significant( P<0.05). The incidence of complications during catheter indwelling in the study group (7.50%) was significantly lower than that in the control group (30.00%), and the difference was statistically significant( P<0.05). Conclusions:Port of implantable venous infusion in patients with ovarian cancer chemotherapy and PICC have their respective advantages.PICC has the advantages of simple operation and high success rate of catheterization, while the implantable intravenous infusion port has the advantages of long indwelling time and less complications, so the appropriate intravenous chemotherapy route can be selected according to the actual situation of patients.